FR-73966

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameFR-73966
Drug Alias NameFR-73966
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuropeptide Y receptor type 5 antagonists
TargetsNeuropeptide Y receptor type 5
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFujisawa Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFujisawa Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A